Affiliation:
1. Department of Biochemistry, Chemistry and Pharmacy, Institute for Pharmaceutical Chemistry Goethe University Frankfurt Germany
2. Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences Goethe University Frankfurt Germany
Abstract
AbstractInduction of Atg8‐family protein (LC3/GABARAP proteins in human) interactions with target proteins of interest by proximity‐inducing small molecules offers the possibility for novel targeted protein degradation approaches. However, despite intensive screening campaigns during the last 5 years, no potent ligands for LC3/GABARAPs have been developed, rendering this approach largely unexplored and unsuitable for therapeutic exploitation. In this Viewpoint, we analyze the reported attempts identifying LC3/GABARAP inhibitors and provide our own point of view why no potent inhibitors have been found. Additionally, we designate reasonable directions for the identification of potent and probably selective LC3/GABARAP inhibitors for alternative therapeutic applications.
Funder
Deutsche Forschungsgemeinschaft
Subject
Cell Biology,Molecular Biology,Biochemistry
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献